Lalit Kumar

9PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Foetal development and medicineMedical mycologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 24, 2025
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India.

Sneh Bhargave, Vinod Sharma, Babita Kataria

|Jun 15, 2023
Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution.

Chethan R, Prabhat Singh Malik, Ranjit Kumar Sahoo

|Feb 16, 2023
Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India.

Dharna Gupta, Ashish Singh, Nidhi Gupta

|Nov 23, 2022
Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome.

Lalit Kumar, Ranjit Kumar Sahoo, Sudhir Kumar

|May 02, 2022
Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial.

Sudhir Kumar, Atul Sharma, Prabhat Singh Malik

|Aug 16, 2021
Impact of microbial contamination of haematopoietic stem cells on post-transplant outcomes: A retrospective study from tertiary care centre in India.

Vikas Garg, Parul Kodan, Deepam Pushpam

Pageof 2

Frequent Collaborators

2 joint publications

Atul Sharma

2 joint publications

Ritu Gupta

1 joint publications

Prasanth Ganesan

1 joint publications

Neha Pathak